IHI Fees and Costs — iShares U.S. Medical Devices ETF
Data updated: 2026-08-24
The net expense ratio is 0.38%. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $65K in broker commissions, 0.0016% of average net assets, and portfolio turnover was 16%.
IHI Fees and Expenses
Annual operating expenses and sales charges of IHI. Prospectus, as of March 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.38% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.00% |
| Gross expense ratio | 0.38% |
| Fee waiver | — |
| Net expense ratio | 0.38% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | No |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
IHI Costs Over Time
On $10,000 invested in IHI, assuming 5% a year before costs, total costs come to $242 over 5 years, cutting the return by 0.40% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.38%) | $40 | $125 | $219 |
| Trading costs (broker commissions) | $0 | $1 | $1 |
| Lost growth on money paid in costs | $0 | $6 | $22 |
| Total costs | $40 | $132 | $242 |
| Value after costs | $10,460 | $11,444 | $12,521 |
| Impact on return, per year | 0.40% | 0.40% | 0.40% |
IHI Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending March 31, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0016%
- Total broker commissions: $65K
- Bought from dealers (principal trades, not a cost): $3.5B
- Portfolio turnover (prospectus): 16%
- Securities on loan, average value: $86.2M
- Net income from securities lending: $198K (0.005% of average net assets)
IHI Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| BNP Paribas Securities Corp. | $28K | 45.58% |
| BofA Securities, Inc. | $9K | 14.34% |
| Goldman Sachs & Co. LLC | $9K | 14.03% |
| Wells Fargo Securities, LLC | $4K | 6.86% |
| UBS Securities LLC | $3K | 5.46% |
| Oppenheimer & Co. Inc. | $3K | 4.64% |
| Cantor Fitzgerald & Co. | $2K | 2.92% |
| Cowen and Company, LLC | $2K | 2.76% |
| Morgan Stanley & Co. LLC | $1K | 1.81% |
| Piper Sandler & Co. | $1K | 1.61% |
IHI Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| Jane Street Capital, LLC | $800.1M | 22.95% |
| RBC Capital Markets, LLC | $667.3M | 19.15% |
| Goldman Sachs & Co. LLC | $560.7M | 16.09% |
| Morgan Stanley & Co. LLC | $288.9M | 8.29% |
| Citigroup Global Markets Inc. | $272.6M | 7.82% |
| BofA Securities, Inc. | $239.7M | 6.88% |
| BNP Paribas Securities Corp. | $230.1M | 6.60% |
| ABN Amro Securities (USA) LLC | $199.8M | 5.73% |
| Citadel Securities LLC | $116.9M | 3.35% |
| J.P. Morgan Securities LLC | $109.5M | 3.14% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.